JPS6314693A - Plant virus rna vector - Google Patents

Plant virus rna vector

Info

Publication number
JPS6314693A
JPS6314693A JP61158443A JP15844386A JPS6314693A JP S6314693 A JPS6314693 A JP S6314693A JP 61158443 A JP61158443 A JP 61158443A JP 15844386 A JP15844386 A JP 15844386A JP S6314693 A JPS6314693 A JP S6314693A
Authority
JP
Japan
Prior art keywords
rna
coat protein
transcription
gene
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61158443A
Other languages
Japanese (ja)
Inventor
Yoshimi Okada
岡田 吉美
Tetsuo Han
飯 哲夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd, Sumitomo Chemical Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP61158443A priority Critical patent/JPS6314693A/en
Publication of JPS6314693A publication Critical patent/JPS6314693A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:A plant virus RNA vector useful for transformation of plant cell, obtained by replacing a coat protein gene range of tobamovirus with an adventitious gene. CONSTITUTION:Plasmid pBR325 containing chloramphenicol acetyltransferase (CAT) gene derived from Escherichia coli HB101 strain is treated with restriction enzyme to construct pCL29 (A) having a coat protein gene range of tobacco mosaic virus (TMV) of pLFW3 replaced with CAT gene. On the other hand a fragment of pt5L29 is linked to a fragment of ptC3L5-2 to construct pCLB29 (B). Then the components A and B are digested with MluI, subjected to transcription reaction with Escherichia coli RNA polymerase and prepared RNA is purified by phenol extraction and ethanol precipitation.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は、植物ウィルスRN A−ベクター、該RNA
ベクター製造用転写・ベクターお、1、びこれらの製造
法並びに植物細胞への外来遺伝子の導入方法に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to plant viral RNA vectors,
This invention relates to transcription vectors for producing vectors, vectors 1 and 1, methods for producing these, and methods for introducing foreign genes into plant cells.

・従来技術 トバモウイルス(tobamovi rus)は、タバ
コ、トマト、ササゲ、キュウリ等の植物から分離される
棒状RNAウィルスであり、タバコ、トマト等を宿主と
するタバコモザイクウィルス(TMV)及びキュウリ等
を宿主Aするキュウリ緑斑モザイクウィルス(CGMM
V)等がこれに属する。
・Prior art Tobamovirus is a rod-shaped RNA virus isolated from plants such as tobacco, tomatoes, cowpeas, and cucumbers.Tobacco mosaic virus (TMV), which uses tobacco and tomatoes as hosts, and cucumbers, etc., as hosts A. cucumber green spot mosaic virus (CGMM)
V) etc. belong to this category.

TMVは、タバコから単離された普通系、トマト、ササ
ゲから単離されたトマト系やササゲ系等の数種類がある
ことが知られている。
It is known that there are several types of TMV, such as a common type isolated from tobacco, a tomato type and a cowpea type isolated from tomatoes and cowpeas.

すでに、トマト系T、MV−L株やその弱毒株TMV−
LIIA株等の数種類のトバモウイルスの塩基配列が決
定され、報告されている(例えば、NishiN15h
i et al、: Nucleic、 Ac1ds 
Res、 13゜5585 (1985);開田:細胞
工学Vo1.4. No、11. P、979−990
  (19’85) ”)。
Already, tomato T and MV-L strains and its attenuated strain TMV-
The nucleotide sequences of several types of tobamoviruses such as the LIIA strain have been determined and reported (for example, NishiN15h
i et al: Nucleic, Ac1ds
Res, 13°5585 (1985); Kaida: Cell Engineering Vol. 1.4. No, 11. P, 979-990
(19'85)").

また、TMV−L株およびTMV−L、、A株RNAの
完全長cDNAを作成し、これをアールキスト(Ahl
quist)らの開発した転写ベクターpPM1へクロ
ーニングし、これを線状化した後、大腸菌のRNAポリ
メラーゼでインビトロ転写反応を行い感染性TMV−R
NAを再生することに成功している。
In addition, we created full-length cDNA of TMV-L strain and TMV-L, A strain RNA, and used it with Ahlquist (Ahlquist).
After cloning into the transcription vector pPM1 developed by E.
Successfully regenerated NA.

本発明らは、1〜バモウイルスRNAを植物細胞の形質
転換に用いる植物ベクターに利用する目的で更に研究を
進め、本発明を完成した。
The present inventors further conducted research for the purpose of utilizing vamovirus RNA as a plant vector for use in transforming plant cells, and completed the present invention.

発明の概要 本発明は、植物細胞への外来遺伝子の導入に用いるRN
Aベクター、該1’?NAベクターの製造用転写ベクタ
ーおよびこれらを製造する方法および植物細胞への外来
遺伝子の導入方法を提供する。
Summary of the Invention The present invention provides an RN for use in introducing foreign genes into plant cells.
A vector, said 1'? Provided are transcription vectors for producing NA vectors, methods for producing them, and methods for introducing foreign genes into plant cells.

発明の詳細な説明 本発明のRNAベクターは、I・ハモウィルスのコート
タンパク遺伝−j’pfl域を所望の外来遺伝子で置換
することにより製造することができる。
DETAILED DESCRIPTION OF THE INVENTION The RNA vector of the present invention can be produced by replacing the coat protein gene-j'pfl region of I. hamovirus with a desired foreign gene.

トバモウイルスのゲノムには、ウィルス複製に関与して
いるタンパクであるとtll、定されている2種類のタ
ンパク、30にタンパクおよびコートタンパクの4種類
のタンパクがコードされていることが知られており、T
MVについて言えば、130にタンパクおよびそのリー
ドスルータンパクである180にタンパク、30にタン
パクおよびコートタンパクの4種類の遺伝子から成り立
っていることが知られている。 本発明のRNAベクタ
ーは、このコートタンパクをコードする遺伝子領域を外
来遺伝子で置換することにより製造することができる。
It is known that the tobamovirus genome encodes four types of proteins: two types of proteins, which have been identified as tll, which are involved in virus replication, a 30-year-old protein, and a coat protein. , T
Regarding MV, it is known that it consists of four types of genes: protein 130 and its read-through protein 180, protein 30, and coat protein. The RNA vector of the present invention can be produced by replacing the gene region encoding this coat protein with a foreign gene.

このRNAベクターの製造は、以下の工程により実施す
ることができる。
This RNA vector can be produced by the following steps.

1)ウィルスRNAの完全長cDNAを合成2)ウィル
スRNAの完全長cDNAのコートタンパクをコードす
る領域が外来遺伝子で置換された完全長の組み換えcD
NAを含む転写ベクターを構築 3)上記の転写ベクターを線状化 4)線状化された転写ベクターを常法によりRNAポリ
メラーゼによる転写反応を行い、目的の組み換えRNA
ベクターを製造する。
1) Synthesis of full-length cDNA of viral RNA 2) Full-length recombinant cD in which the coat protein coding region of full-length cDNA of viral RNA is replaced with a foreign gene
Construction of a transcription vector containing NA 3) Linearize the above transcription vector 4) Perform a transcription reaction using RNA polymerase on the linearized transcription vector by a conventional method to obtain the desired recombinant RNA.
Manufacture the vector.

この際、m ’ G ppp Gの存在下にRN Aポ
リメラーゼにより転写反応を行い、RN Aの5゛末端
をキャップ構造でブロックした場合には、植物細胞への
組み換えRNAの感染性が顕著に増大するが、RNAの
5゛末端をキャンプ構造でブロックすることは必須では
ない。 また、RNAの3゛末端については、3゛末端
を越えて多くのヌクレオチドが接続してないことが望ま
しく、転写ベクターによるcDNAからのRNAの転写
に際し、RNAの3゛末端で正illに転ffj゛が終
了することが望ましい。 この為に、鋳型となるcDN
A3”末端の直近に適当な制限酵素(例えば、M l 
u T )による切断部位を組め込み、転写の前に、そ
こでcDNAを切断することにより転写を停止させるこ
とが望ましい。
At this time, if the transcription reaction is performed with RNA polymerase in the presence of m'G ppp G and the 5' end of the RNA is blocked with a cap structure, the infectivity of the recombinant RNA to plant cells increases markedly. However, it is not essential to block the 5' end of the RNA with a camp structure. Furthermore, regarding the 3' end of RNA, it is desirable that many nucleotides not be connected beyond the 3' end, so that when transcribing RNA from cDNA using a transcription vector, the 3' end of the RNA is transferred to the positive ill. It is desirable that ゛ be completed. For this purpose, cDNA as a template is
Insert an appropriate restriction enzyme (e.g., M
It is desirable to incorporate a cleavage site by u T ) and terminate transcription by cleaving the cDNA there prior to transcription.

上述の転写ベクターとしては、複製開始領域、選択マー
カー、プロモーターおよび転写開始点の直後に鋳型とな
るDNAの挿入部位および挿入されたDNAのすぐ下流
に制限酵素切断部位を有するすでに公知の転写・ベクタ
ーを用いることができる。 例えば、アールキスト(A
hlquist)の開発したpPMl等(本ベクターに
関しアグリジエネテイクス リサーチ アソシエイツ 
リミテッドが特許出願:公開特許公報 昭和61年57
79号を出願しており、本ベクターを業として使用する
場合は、権利者の承諾を必要とする。本願発明に至る実
験において、アールキスト氏から提供されたpPMlを
用いた。)の公知の転写ベクターを用いることができる
The above-mentioned transcription vectors include already known transcription vectors that have a replication initiation region, a selection marker, a promoter, a template DNA insertion site immediately after the transcription initiation site, and a restriction enzyme cleavage site immediately downstream of the inserted DNA. can be used. For example, Ahlquist (A
pPMl etc. (this vector was developed by AgriGenetics Research Associates)
Limited filed a patent application: Published Patent Publication 1986 57
No. 79 has been filed, and if this vector is to be used commercially, the consent of the right holder is required. In the experiments leading to the present invention, pPMl provided by Mr. Ahlquist was used. ) can be used.

pPMlは、転写が挿入したcDNAの一番端から開始
し、RNAの3゛末端に相当する部分に制限酵素部位を
有し、この部位で切断し線状化後、転写することにより
ウィルスRNAの3”末端をこえて感染性に影響を与え
る程度の余分なヌクレオチドを接続しないように工夫さ
れた転写用ベクターである。
In pPMl, transcription starts from the very end of the inserted cDNA, and it has a restriction enzyme site at the part corresponding to the 3' end of the RNA. It cuts at this site, linearizes it, and then transcribes the virus RNA. This is a transcription vector designed to avoid connecting extra nucleotides beyond the 3'' end that would affect infectivity.

本発明において、ベクターとして使用するトバモウイル
スとしては、トマト系、普通系、ササゲ系等のTMVお
よびCGMMVを用いることができる。 野生株および
植物に対し病徴を生じない感染性を示す自然度)°−株
あるいは組み換え技術により変異を生じさ−U弱毒化し
たものを用いることが可能である。
In the present invention, tobamoviruses used as vectors include tomato-based, common-based, cowpea-based TMV and CGMMV. It is possible to use wild-type strains and strains that exhibit infectivity without causing disease symptoms or attenuated strains that have been mutated by recombinant technology.

ウィルスRNへの完全14のc I) N Aは、逆転
写酵素でRNAを逆転7ノ°する公知の方法で容易に作
成することができる。 例えば、1’ M V −L株
のゲノムRNA (1〜(7215番11)のcDN、
Aおよび3°末端1’、6KbのcDNA、並びにTM
V、L++A株の完全長c、 I) N Aをクローニ
ングしたプラスミドp L T −1) 27、  p
L−1−13およびpL++A  A25などが公知で
あり、それぞれ0hno etal、:J、旧oche
m、りfi、 1915−1923(1984) 、 
Takamastu  cl  al、:Nucl e
ic  Ac1ds  Res、 11.3767−3
778(1983) 、およびNishiguN15h
i al、 :Nucleic Ac1ds Res、
 13.5585−5590(1985)に記載の方法
で製造できる。
A complete 14 c I) NA to viral RNA can be easily created by a known method of inverting the RNA 7 times with reverse transcriptase. For example, the genomic RNA of the 1' MV-L strain (cDNA of 1 to (7215 No. 11),
A and 3° end 1', 6 Kb cDNA, and TM
V, L++A strain full-length c, I) Plasmid pLT-1) cloned with NA 27, p
L-1-13 and pL++A A25 are known, respectively.
m, Rifi, 1915-1923 (1984),
Takamastucl al, :Nucle
ic Ac1ds Res, 11.3767-3
778 (1983), and NishiguN15h
ial, : Nucleic Ac1ds Res,
13.5585-5590 (1985).

本発明のRNAベクターの製造に鋳型として用いられる
DNAは、ウィルスT?NAの完全長cDNAのコート
タンパクの遺伝子1irf域を外来遺伝子DN、Aで置
換したI) N Aを転写ベクターに組み込むことによ
り製造されるが、この組み換え転写ベクター自体の構築
は、遺伝子組み換えで用いられる常法を用いることによ
り行うことができる。
The DNA used as a template for producing the RNA vector of the present invention is virus T? I) The gene 1irf region of the coat protein of the full-length NA cDNA is replaced with a foreign gene DNA, A.It is produced by incorporating NA into a transcription vector, but the construction of this recombinant transcription vector itself requires genetic recombination. This can be done by using a conventional method.

特に、第2図に示した転写ベクターpLDC329の如
くトバモウイルスRNAのcDNAのコートタンパク遺
伝子領域を除去し、この部分に外来遺伝子の挿入を可能
にする制限酵素切断部位を導入することにより構築した
複製開始領域、選択マーカー、プロモーターおよびコー
トタンパク遺伝子領域が外来遺伝子挿入のための制限酵
素切断部位へ変換された配列のトバモウィルスRNAの
cDNAから成り、該プロモーターの転写開始ヌクレオ
チドが該cDNAの最初のヌクレオチドであるように接
続されているユニバーサル転写ベクターを用いることに
より容易に行うことができる。
In particular, a replication vector constructed by removing the coat protein gene region of the tobamovirus RNA cDNA and introducing a restriction enzyme cleavage site that enables insertion of a foreign gene into this region, such as the transcription vector pLDC329 shown in Figure 2, is constructed. It consists of a cDNA of tobamovirus RNA in which the region, selection marker, promoter, and coat protein gene region have been converted into restriction enzyme cleavage sites for foreign gene insertion, and the transcription initiation nucleotide of the promoter is the first nucleotide of the cDNA. This can be easily done by using a universal transcription vector that is connected as follows.

このユニバーサル転写ベクターの外来遺伝子挿入部位に
所望の遺伝子を通常の遺伝子組み換え技術を用い挿入す
ることにより目的とする転写ベクターを構築することが
できる。
A desired transcription vector can be constructed by inserting a desired gene into the foreign gene insertion site of this universal transcription vector using conventional genetic recombination techniques.

本発明により植物細胞へ導入される遺伝子としては、特
に限定されるものではないが、例えば、高温や低温に対
する耐性を改善する遺伝子、霜、害虫、病原微生物、ウ
ィルス等に対する耐性を改善する遺伝子、除草剤に対す
る耐性を改善する遺伝子、植物の成長に関与する遺伝子
、窒素固定化に関与する酵素等、光合成に関Jjする遺
伝子、植物の栄養上の特性や風味に関ずろ遺伝子、有用
物質の遺伝子など種々の遺伝子が挙げられる。
Genes introduced into plant cells according to the present invention are not particularly limited, but include, for example, genes that improve resistance to high and low temperatures, genes that improve resistance to frost, pests, pathogenic microorganisms, viruses, etc. Genes that improve tolerance to herbicides, genes involved in plant growth, enzymes involved in nitrogen fixation, genes related to photosynthesis, genes related to nutritional characteristics and flavor of plants, genes for useful substances Various genes can be mentioned.

植物細胞の形質転換&、l: 、1.述のようにして作
成した組み換えRNΔベクターを植物細胞へ感染させる
ことにより行うことができる。 この際、ウィルスのコ
ートタンパクを用いウィルスの再構成を行った後に、植
物−・接種!l−るごとにより植物細胞へ感染させるこ
とに、1、す、感梁率を増大させることができる。 植
物細11;シへの感染は、再構成反応液を必要に応じ水
、緩衝液等で適゛1′Iな濃度へ希釈後、あるいはウィ
ルスまたはI’? N Aを緩衝液等で懸濁しカーボラ
ンダJ、と共に植物・\接種することにより行うことに
より容易に行うことができる。
Transformation of plant cells &,l: ,1. This can be carried out by infecting plant cells with the recombinant RNAΔ vector created as described above. At this time, the virus is reconstituted using the virus coat protein, and then the plants are inoculated! By infecting plant cells with the same method, the sensitivity can be increased. Infection of plants is carried out by diluting the reconstituted reaction solution with water, buffer, etc. as necessary to an appropriate concentration, or by infecting viruses or I'? This can be easily carried out by suspending NA in a buffer solution or the like and inoculating the plant together with Carbolanda J.

対象となる植物とし“ζは、例えば、タバコやトマド等
のトバモウイルスが感染しうるちのであればよく、特に
制限はない。
The target plant "ζ" is not particularly limited as long as it is a plant that can be infected with tobamovirus, such as tobacco or tomato.

以下に実施例を挙げ本発明を更に詳細に説明する。The present invention will be explained in more detail with reference to Examples below.

本発明は、この実施例にのみ限定されるものではなく、
本発明の技術分野において通常なされる変更および改良
を含むものである。
The present invention is not limited only to this example,
It is intended to include modifications and improvements commonly occurring in the art to which the invention pertains.

RNAベクターのcDNAの構築 TMVのコートタンパク遺伝子領域を外来遺伝子で置換
したcDNAを含む組み換えcDNAを以下のように製
造した。
Construction of cDNA of RNA Vector A recombinant cDNA containing a cDNA in which the coat protein gene region of TMV was replaced with a foreign gene was produced as follows.

なお、本実施例においてDNAのクローニングには、大
腸菌H8101株を用いた。
In this example, E. coli strain H8101 was used for DNA cloning.

■)完全長のクロラムフェニコール アセチルトランス
フェラーゼ(chloramphenicol ace
tyltransferase : CA T )遺伝
子を含むプラスミドp B R325(F、Boliv
ar、 Gene 4,121  (197B) )か
らBan1フラグメントを切出し、大腸菌DNAポリメ
ラーゼIのクレノー(KlenolII)フラグメント
を用いフィルインした後、5au3AIで消化すること
により0.74Kbフィルド−イン+13 a n I
 / S a u 3 A Iフラグメン(CATの全
コード領域、 59bpの5゛非翻訳領域および24b
pの3°非翻訳領域を含む)を単離した。
■) Full-length chloramphenicol acetyltransferase
Plasmid pBR325 (F, Boliv) containing the tyltransferase: CAT) gene
ar, Gene 4,121 (197B)), filled in using the Klenol II fragment of E. coli DNA polymerase I, and digested with 5au3AI to create a 0.74 Kb filled-in + 13 a n I.
/ S au 3 A I fragment (entire coding region of CAT, 59 bp of 5' untranslated region and 24 b
(including the 3° untranslated region of p) was isolated.

転写ベクターpl)、Mlへ′I″MV−Lの完全長c
DNAを組み込んだ公知の転写ベクターpLFW3 (
石川ら: 第11川11本分子生物学会年会(1985
))をA V ;J I+で消化し1” M V −1
−のゲノムRNAの61fliO化+1に相当する個所
で切断し、クレノー(KIcnc++u)フラグメント
を用いフィルインした後、更にi’ M Vのr、 l
) NΔの4bpT流において3allで消化すること
によりTMVの3゛末端部分および:I−1タンパク遺
伝子の22bpを含む0 、2 :(’I< bの)2
fルド−インAvall/5allDNA断片を得た。
Transcription vector pl), full-length c of 'I''MV-L into Ml
A known transcription vector pLFW3 incorporating DNA (
Ishikawa et al.: 11th Annual Meeting of the Molecular Biology Society (1985)
)) was digested with AV;
- genomic RNA was cut at a site corresponding to 61fliO-ylation +1, and filled in using a Klenow (KIcnc++u) fragment, and then r, l of i' MV
) 0,2:('I<b)2 containing the 3' terminal part of TMV and 22 bp of the I-1 protein gene by digesting with 3all in the 4bp T stream of NΔ
A f domain Avall/5all DNA fragment was obtained.

 これらの2フラグメントを結合後、p1目ン322の
13 a m HIと5allザイlの間にりu −=
 7グし、pCAT3L−10を構築した。
After joining these two fragments, u −=
pCAT3L-10 was constructed.

pcAT31、−IOをp BI? 322由来のEc
oRVサイトで切断し、 綿状化した後、Ba131エ
キソヌクレアーゼで<  0.6Ml  1− NaCl、20mMTr 1s−HCj!  (pH8
)  、12mM  MgCj!、、 12mM  C
aCj!2.11.6μgpCAT3L−to /gc
、oRV、2.6’uBa131エキソヌクレアーゼを
含む反応液中、30℃、7,5分間反応”)CAT遺伝
子の開始コドンの近くまで切り詰めた。
pcAT31, -IO pBI? Ec derived from 322
After cutting at the oRV site and flocculization, <0.6 Ml 1-NaCl, 20mM Tr 1s-HCj! with Ba131 exonuclease. (pH8
), 12mM MgCj! ,, 12mM C
aCj! 2.11.6μgpCAT3L-to/gc
, oRV, and 2.6'uBa131 exonuclease at 30° C. for 7.5 minutes.

これに5acIリンカ−(1)dCGAGCTCG)を
接続し、5aclおよび5allで消化した後、CAT
遺伝子およびTMVの全3゛非翻訳領域を含むDNA−
t−pUCl 8の5aCIおよび5allサイトの間
にクローニングした。 結合反応液を用いE、coli
HBlolを形質転換し、アンピシリンおよびクロラム
フェニコールに耐性のコロニーからプラスミドを単離し
た。
A 5acI linker (1) dCGAGCTCG) was connected to this, and after digestion with 5acl and 5all, CAT
DNA containing the gene and all 3 untranslated regions of TMV-
It was cloned between the 5aCI and 5all sites of t-pUCl 8. Using the binding reaction solution, E. coli
HBLol was transformed and plasmids were isolated from colonies resistant to ampicillin and chloramphenicol.

グイデオキシ法でDNA配列を決定し、1obpの5゛
 リーダー領域を゛含むCAT遺伝子およびTMVの3
゛末端およびコートタンパクの一部を含むptC3L″
5−2・を選択した。
The DNA sequence was determined by the guideoxy method, and the CAT gene containing the 1 obp 5' leader region and 3 of TMV were sequenced.
``ptC3L containing the terminal end and part of the coat protein''
5-2. was selected.

一方、p 、L F W 3コートタンパク遺伝子領域
中(7)BstEIrサイト(TMVゲノムRNAの5
799番目に相当する部位))で消化し、 Ba131
エキソヌクレアーゼで(0,6MNa’Cp220mM
Tr i 5−HC7! (pl+8.0) 、12m
 M M g C7!t、l 2mMCaCj!z 、
10.ljgP L F W 3 / Tl s L 
l’: Tl、1.3uBa 131mmキスクレアー
ゼを含む反応液中、30℃、3分間反応)コートタンパ
ク遺伝子の開始コドンの近くまで切り詰めた。 これに
S 、J(二[リンカ−を接続した後、Sa c’ l
およびK p n T’ (TMVゲノムの4390番
口に相当する部位)で消化した。
On the other hand, p, LFW 3 coat protein gene region (7) BstEIr site (TMV genomic RNA 5
Digested at the site corresponding to position 799)), Ba131
With exonuclease (0,6M Na'Cp220mM
Tri 5-HC7! (pl+8.0), 12m
M M g C7! t,l 2mMCaCj! z,
10. ljgP L F W 3 / Tl s L
l': Tl, 1.3 uBa 131 mm Reacted at 30° C. for 3 minutes in a reaction solution containing kiss crease) It was truncated to the vicinity of the start codon of the coat protein gene. To this, S, J (2[After connecting the linker, Sac' l
and K p n T' (a site corresponding to opening 4390 of the TMV genome).

コートタンパクの上流を含む1.25〜1.35Kbの
S a c I / K p n Iフラグメントをp
U’C18のSac■およびに’pn!リーイトの間に
クローニングした。 上記と同様に大腸菌を形質転換後
、プラスミドを単離、1.) N A配列を決定し、T
MVの30にタンパク遺伝子、180にタンパク遺伝子
の一部およびコートタンパク遺伝子A’TGに続く4b
pを含むpt5L29を′選択した。
A 1.25-1.35 Kb Sac I/K pn I fragment containing upstream of the coat protein was
U'C18's Sac■ and ni'pn! Cloned during the leak. After transforming E. coli in the same manner as above, isolate the plasmid, 1. ) Determine the NA sequence and T
Protein gene at 30 of MV, part of the protein gene at 180, and 4b following coat protein gene A'TG
pt5L29 containing p was selected.

pCL29の構築: pt5L29の1.32Kbの5acI/Kpnlフラ
グメント(180にタンパク遺伝子の一部、30にり、
ンパク遺伝子およびコートタンパク遺伝子の開始コドン
およびその下流4bpを含む)、p tc3L5−2の
0.963Kbの5acl/M I u Iフラグメン
ト(CAT遺伝子およびその上流10bp並びにTMV
の3゛末端領域を含む)およびpLFW3のKpnl/
Mlulフラグメントを結合しpCL29を構築した。
Construction of pCL29: 1.32 Kb 5acI/Kpnl fragment of pt5L29 (part of the protein gene at 180, part of the protein gene at 30,
protein gene and coat protein gene (including the start codon and 4 bp downstream thereof), a 0.963 Kb 5 acl/M I u I fragment of ptc3L5-2 (including the CAT gene and 10 bp upstream thereof, and TMV
) and Kpnl/ of pLFW3
The Mlul fragment was ligated to construct pCL29.

このpCL29は、pLFW3のTMVコートプロティ
ン遺伝子領域をCAT遺伝子で置換された構造を有する
This pCL29 has a structure in which the TMV coat protein gene region of pLFW3 is replaced with the CAT gene.

p CL B 29の構築: pt5L29の5acl/Kpnlフラグメントおよび
p tC3L5−2の5acI/M1uIフラグメント
の5aclサイトをクレノーフラグメントでフィルアウ
トし平滑末端とした後、pCL29構築と同様に結合し
p CLB 29を構築した。
Construction of pCLB 29: The 5acl sites of the 5acl/Kpnl fragment of pt5L29 and the 5acI/M1uI fragment of ptC3L5-2 were filled out with Klenow fragment to make blunt ends, and then ligated in the same manner as for pCL29 construction. was built.

ユニバーサル転写ベクターpLDC329の構築:コー
トタンパク遺伝子領域を除去し、この部分に外来遺伝子
の挿入を可能にする制限酵素切断部位(Sacl)を導
入したユニバーザル転写ベクターpLDcs29を以下
のように、構築した。
Construction of universal transcription vector pLDC329: Universal transcription vector pLDcs29 was constructed as follows, in which the coat protein gene region was removed and a restriction enzyme cleavage site (Sacl) was introduced into this region to enable insertion of a foreign gene.

pLFW3をA V a IIで消化、クレノーフラグ
メントでフィルインした後、3 a c、 lリンカ−
を接続し、5aclおよびM l u Iで消化し、0
.23Kbの5acl/Mlulフラグメント(TMV
の3゛非翻訳領域およびコートタンパクのC末端22b
pを含む)を単離した。
After digesting pLFW3 with A Va II and filling in with Klenow fragment, 3 a c, l linker
connected, digested with 5acl and M l u I, 0
.. 23Kb 5acl/Mlul fragment (TMV
3゛untranslated region and C-terminal 22b of coat protein
p) were isolated.

このSa c I/Ml uIフラグメントをpt5L
29から単離した1、32Kbの5acl/Kpnlフ
ラグメントおよびpL、FW3から単離したK p n
 I / M 、1 u Iフラグメント(大きい方の
フラグメントを使用)と結合し、コートタンパク遺伝子
の5710−6160番目が除かれ5aclサイトを挿
入されたpLDcs29を構築した。
This SacI/MluI fragment was converted into pt5L
1, 32 Kb 5acl/Kpnl fragment isolated from 29 and pL, Kpn isolated from FW3
I/M, 1 u I fragment (the larger fragment was used) to construct pLDcs29 in which positions 5710-6160 of the coat protein gene were removed and the 5acl site was inserted.

転写: 上記のように製造した転写ベクターpCL29、pCL
B29をM I IJ Iで消化後、大腸菌RNAポリ
メラーゼを用い公知法 (AI+1quist et 
al。
Transcription: Transcription vector pCL29, pCL produced as above
After digesting B29 with M I I J I, a known method (AI+1quist et al.
al.

Proc、 Natl、 Acad、 Sci、 ll
5A 01.7066−7070(1984)により転
写した。 得られたRNAをフェノール抽出およびエタ
ノール沈澱で精製した。
Proc, Natl, Acad, Sci, ll
5A 01.7066-7070 (1984). The resulting RNA was purified by phenol extraction and ethanol precipitation.

これを公知の酢酸法(Fraenkel −Conra
t、H。
This is carried out using the known acetic acid method (Fraenkel-Conra).
t, H.

Virology 4.1−4(1957))で精製し
たTMVの普通株のコートタンパク(4m g / m
 j! )を用い0、!Mリン酸ナナトリウム緩衝液p
H7,0)中で20℃で16時間処理しウィルス粒子再
構成を行った。
The coat protein of a common strain of TMV (4 mg/m
j! ) using 0,! M sodium phosphate buffer p
Virus particles were reconstituted by treatment in H7,0) at 20°C for 16 hours.

植物細胞への感染および発現: 上記のように再構築した反応液を緩衝液で5倍に希釈し
、N1cotiana tabacum Samsun
  の葉に塗布した。 10日栽培した後、葉を採集し
抽出液(250mMTris−HCj! (pH7,5
)、2.5mM  EDTA、0.1%アスコルビン酸
、0.5mMロイペプチン、1 mMPMsF)を加え
、磨砕し、60℃で10分間加温した。 遠心分離(1
4,000x g、5分)後、上清を緩衝液で10.0
μnとし5μlの10mMアセチルCoAおよび0.0
67μCiの14Cラベル−クロラムフェニコール(5
3mCi /mmo I ;アマシャム)と混合し37
℃で30分間インキュベートした。 クロラムフL二二
1−ルおよびその誘導体を酢酸エチルで抽出し、減圧下
に乾固した後、5μlの酢酸エチルに懸濁した。
Infection and expression of plant cells: The reaction solution reconstituted as above was diluted 5 times with buffer solution, and N1cotiana tabacum Samsun
applied to the leaves. After 10 days of cultivation, the leaves were collected and extracted with an extract (250mM Tris-HCj! (pH 7,5
), 2.5mM EDTA, 0.1% ascorbic acid, 0.5mM leupeptin, 1mM PMsF) were added, ground, and heated at 60°C for 10 minutes. Centrifugation (1
After (4,000 x g, 5 min), the supernatant was diluted with buffer at 10.0
μn and 5 μl of 10 mM acetyl-CoA and 0.0
67 μCi of 14C-labeled chloramphenicol (5
3 mCi/mmo I; Amersham) and 37
Incubated at ℃ for 30 minutes. Chloramfluor L-221- and its derivatives were extracted with ethyl acetate, dried under reduced pressure, and then suspended in 5 μl of ethyl acetate.

このLPfi+液をクロロポルノ、/メタノール(95
:5)を溶媒としシリガゲル薄層り11マドグラフイー
にかけ、 クロラムソ丁−二ごI−)しおよびそのアセ
チル誘導体(lAccm:l  アセチルクロラムフェ
ニコール、 3AcCr++:3−アセチルクロラムフ
ェニコール、  I、3AcCrrz l、3−ジアセ
チルクロラムフェニコール)をオートラジオグラフィー
(室温、16時間)により検出した。 結果を第6図に
示す。 この図中、レーンlは、未反応14 Cラヘル
−りロラムフェニコール(Cm) 、レーン、2は、転
回反応液を塗布してない対象植物の葉0.5mgの抽出
物、レーン3は野生株のTMVを感染させた植物の抽出
物、レーン4は、コートタンパク遺伝子を有しない転写
ベクターpLD、C329の転写産物、レーン5および
6は、pCL29およびpCLI329の転写塵物を塗
布した植物の抽出物のものである。 レーン7は、0.
03単位のCATの反応物のものである。
This LPfi+ liquid was mixed with chloroporne/methanol (95
: 5) as a solvent and subjected to silica gel thin layer layer 11 madography, chloramsodic chloramphenicol I-) and its acetyl derivative (lAccm:l acetylchloramphenicol, 3AcCr++: 3-acetylchloramphenicol, I, 3AcCrrz 1,3-Diacetylchloramphenicol) was detected by autoradiography (room temperature, 16 hours). The results are shown in Figure 6. In this figure, lane 1 is unreacted 14C-raherylloramphenicol (Cm), lane 2 is an extract of 0.5 mg of leaves of the target plant to which the rotation reaction solution has not been applied, and lane 3 is Lane 4 is the transcript of the transcription vector pLD, C329, which does not have the coat protein gene. Lanes 5 and 6 are the extract of the plant infected with the wild-type TMV. It is an extract. Lane 7 is 0.
03 units of CAT reactant.

この結果から明らかなように、pCL29およびpCL
B29によるCATの発現が確認された。
As is clear from this result, pCL29 and pCL
Expression of CAT by B29 was confirmed.

参考例 完全長のTMV−LのcDNAを含む転写ベクターpL
FW3の構築: TMV−RNAの完全長cDNAの合成1)TMV−L
株あるいは弱毒株L++Aをタバコに接種し増殖させた
。 感染されたタバコを磨砕後、ウィルス粒子を公知の
方法で精製し、次いでウィルス粒子からRNAを公知法
(TakaIIatu et訂、Nucleic Ac
1ds Res、 11.3767−3778 (19
83))で精製した。このRNAを過剰の合成プライマ
ー (TMV−RNAの3°末端の18残基に相補的な
配列を有する。或いは、必要に応じ、 3゜末端の第9
番目に相当するAをTに変換したものを使用)とアニー
ルした。 このアニールしたRNAを用い、50 II
 l: / m’ 1.のアニールRNAおよび250
単位/ m Iの逆転′す°酵素を含む反応液を調製、
これを42℃、90分間反応しc DNAを合成した。
Reference example: Transcription vector pL containing full-length TMV-L cDNA
Construction of FW3: Synthesis of full-length cDNA of TMV-RNA 1) TMV-L
The strain or attenuated strain L++A was inoculated into tobacco plants and allowed to grow. After grinding the infected tobacco, virus particles were purified by a known method, and then RNA was extracted from the virus particles by a known method (edited by Taka II Atu et al., Nucleic Ac
1ds Res, 11.3767-3778 (19
83)). This RNA was combined with an excess of synthetic primers (having a sequence complementary to the 18 residues at the 3° end of TMV-RNA; or, if necessary, the 9th residue at the 3° end).
(using the A corresponding to the th A converted to T) and annealing was performed. Using this annealed RNA, 50 II
l: / m' 1. annealed RNA and 250
Inversion of units/mI'°Prepare a reaction solution containing the enzyme,
This was reacted at 42°C for 90 minutes to synthesize cDNA.

フェノール抽出、エタノール沈澱によりDNAを回収後
、+1 、1 N N ’a OHによりRNAを分解
した。 これを5〜20% アルカリ−ショ糖密度勾配
遠心あるいは2.5%ポリアクリルアミド/8.3M尿
素ゲル電気泳動にかけ完全長のRNAに相当するcDN
Aを分取した。
After recovering DNA by phenol extraction and ethanol precipitation, RNA was degraded with +1 and 1 N N'a OH. This was subjected to 5-20% alkaline-sucrose density gradient centrifugation or 2.5% polyacrylamide/8.3M urea gel electrophoresis to obtain cDNA corresponding to full-length RNA.
A was collected.

上記のように合成した完全長cD’NAに過剰の合成プ
ライマー(TMV−4Nへの1〜19残基に相当する配
列を有する)を加え! OmMTr i 5−HCI 
  (p  H7,5)  、  I  O’mMMg
C1z 、50mMNaCρ中で、90℃で5分間加熱
した後、徐々に冷却しアニールした。
Add excess synthetic primer (having a sequence corresponding to residues 1 to 19 to TMV-4N) to the full-length cD'NA synthesized as above! OmMTr i 5-HCI
(pH 7,5), IO'mMMg
After heating at 90°C for 5 minutes in C1z and 50mM NaCρ, the sample was gradually cooled and annealed.

このcDNAを1 tlmMTr i 5−HCI!、
(1)’H7’、5) 、2’5mM  NaC7,1
0rr+MM g C12,5mMジ千オスレイ1−ル
、0.2mMの各d N T P中で250中位/m7
!の大腸菌DN−Aポリメラーゼ1ラージフラグメント
を加え21 ”Cで3時間反応し二本鎖cDNAに変換
した。
This cDNA was injected into 1 tlmMTri 5-HCI! ,
(1)'H7', 5), 2'5mM NaC7,1
0rr + MM g C12, 5mM dioxole, 0.2mM each dNTP at 250 medium/m7
! E. coli DNA-A polymerase 1 large fragment was added thereto and reacted at 21''C for 3 hours to convert into double-stranded cDNA.

低融点アガロースゲルにより精製し完全長の二本鎖cD
NAを得た。
Full-length double-stranded cD purified by low melting point agarose gel
Got NA.

完全長cDNAのクローニング pUcG’J1の構築 pUC9のポリリンカー配列部位にMlulサイトを導
入するために、p C09F 2 (Mesi eta
l、 Virology 127.54−64 (19
83) ; cucombergreen mottl
e mosaic virus  のM l u Iサ
イトを含む約1.6Kbを含む)のQ、21 K bの
HindllI/フィル−インM l u Iフラグメ
ントをpU C9(Vieira et al、 Ge
ne 19.259−268 (19B2)のl(i 
n d [7/フィルーイン5allサイトへ挿入しp
UcG91を構築した。
Cloning of full-length cDNA Construction of pUcG'J1 In order to introduce a Mlul site into the polylinker sequence site of pUC9, pC09F 2 (Mesi et al.
l, Virology 127.54-64 (19
83); cucombergreen mottl
The 21 Kb HindllI/Fill-in Mlu I fragment of Q, which contains approximately 1.6 Kb containing the Mlu I site of E. mosaic virus, was transformed into pU C9 (Vieira et al,
ne 19.259-268 (19B2) l(i
n d [7/Fill-in 5all site insert p
UcG91 was constructed.

pUCG91のM I u Iサイト周辺の構造を第5
図にしめす。
The structure around the M I u I site of pUCG91 is
Shown in the diagram.

TM’V=L株の完全長c’ D N Aを含むプラス
ミドpLFWlの構築 1)pLM51およびpLM31の構築上記のようにし
て得られた完全長二本鎖cDN2l− =20 = A (TMV−L株)をB g I IIで消化し、R
NAの5°末端部分に相当する2、62Kbを得た後、
精製した。
Construction of plasmid pLFWl containing full-length c' DNA of TM'V=L strain 1) Construction of pLM51 and pLM31 Full-length double-stranded cDN obtained as above 2l- = 20 = A (TMV-L strain) was digested with B g I II and R
After obtaining 2,62 Kb corresponding to the 5° terminal part of NA,
Purified.

これをp’P’M1のPmプロモーターを含む3.03
KbのAatTI/SmalフラグメントおよびpUC
9の0.47 K bのAaLn/BamHIフラグメ
ントと結合した。  結合したDNAをE、  c  
o  I  iMcl  0 6 1  (Casdr
laban  et  al、:J9Mo1. Bio
l、 138.17’9−207  (1980) )
 ヘ形質転換した。 コロニーハイプリダイジョンおよ
び制限酵素地図を作成し、第4図に示した構造のpLM
5’lを゛含む大腸菌を選択した゛。
3.03 containing the Pm promoter of p'P'M1
AatTI/Smal fragment of Kb and pUC
9 and a 0.47 Kb AaLn/BamHI fragment. The combined DNA is E, c
o I iMcl 0 6 1 (Casdr
laban et al.: J9Mo1. Bio
l, 138.17'9-207 (1980))
transformed into Colony hybridization and restriction enzyme maps were created, and pLM with the structure shown in Figure 4 was created.
E. coli containing 5'l was selected.

2)pLM31の構築 上記のようにしてjitられた完全長二本鎖cDNA(
TMV−’L3°末端の第9番「1のTがAへ変換され
た変異体のr、1)NA)をp s t lで消化し、
RNAの3“末端部分に相当する4、54Kb4得た後
、精製した。
2) Construction of pLM31 The full-length double-stranded cDNA (
No. 9 of the TMV-'L3° end (r of the mutant in which T in 1 was converted to A, 1) NA) was digested with p s t l,
After obtaining 4,54 Kb4 corresponding to the 3'' end portion of the RNA, it was purified.

これをpUC9の2.1IIKbのΔatll/Pst
lフラグメントおよびpUcG91の0.49KbのA
atll/フィルインM I u Iフラグメントを結
合した。 結合したDNAをE、coliMC1061
へ形質転換した。 コロニーハイブリディジョンおよび
制限酵素地図を作成し、第4図に示した構造のpLM3
1を選択した。
This is Δatll/Pst of 2.1IIKb of pUC9.
l fragment and the 0.49 Kb A of pUcG91
The atll/fillin M I u I fragment was ligated. The combined DNA was transferred to E. coli MC1061.
transformed into. Colony hybridization and restriction enzyme maps were created and pLM3 with the structure shown in Figure 4 was created.
I chose 1.

3)pLFWlの構築 pLM31のPstlサイトに、pLM51のPstl
フラグメント(Pmプロモーターおよび5”末端を含む
。)を挿入することにより完全長cDNAを含むpLF
Wlを構築した。
3) Construction of pLFWl Pstl of pLM51 is inserted into the Pstl site of pLM31.
pLF containing the full-length cDNA by inserting the fragment (including the Pm promoter and 5” end)
Wl was constructed.

pLFW3の構築 pLFWlのNcol/Apalフラグメントをp L
 −1−13(Takamatsu et al、Nu
cleicAcids Res、 11.376−37
78 (1983)  :約1 、600bpのTMV
−L株の3°末端の(、DNAを含む。)のNcol/
Apalフラグメントで、EcoR1/Ncolフラグ
メントをpLT7D27 (Ohno  etal、:
J、  Biochem、96. 1915−1923
  (1984):TMV−L株RNAの5”末端から
6215番までのcDNAを含む)のE c o RI
 、/ N c 、o Iフラグメントで置換するごと
により第4図に示した構造のpLFW3がiiIられた
Construction of pLFW3 The Ncol/Apal fragment of pLFWl was pL
-1-13 (Takamatsu et al, Nu
Cleic Acids Res, 11.376-37
78 (1983): approximately 1,600bp TMV
-Ncol/of the 3° end (containing DNA) of the L strain
The EcoR1/Ncol fragment was transformed into pLT7D27 (Ohno et al.:
J. Biochem, 96. 1915-1923
(1984): Eco RI of TMV-L strain RNA (containing cDNA from 5” end to position 6215)
, / N c , o I fragments resulted in pLFW3 having the structure shown in FIG.

pLFAlの構築 上記と同様にp l FW 1のl−Cc o RI 
/ A p a IフラグメントをpLzΔ−八250
)EcoRT/Apalフラグメントで置換することに
よりTMV  L++A株の完全M (: D N A
を3.11み込んだ転写ベクターpLFAIを横築した
Construction of pLFAl As above, l-CcoRI of plFW1
/ A p a I fragment pLzΔ-8250
) of the TMV L++A strain by substitution with the EcoRT/Apal fragment (: DNA
A transcription vector pLFAI containing 3.11 was constructed horizontally.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は、本発明の転写ベクターpCL29構築の概略
を示す図である。 図中Pmは、アールキストの開発したpPM1由来のλ
ファージのプロモーターを表す。 130に/180K、30におよびcpは、TMVの1
30に/180にタンパク遺伝子、30にタンパク遺伝
子およびコートタンパク遺伝子を表す。 その前後の四
角で囲んだ5および3は、それぞれ5°末端非翻訳領域
および3”末端非翻訳領域を表す。 第2図は、ユニバーサル転写ベクターp LDC329
構築の概要を表す図である。 第3図は、CAT遺伝子を含む転写ベクターpCL29
 (pCL、B29) 、転写ベクターp LDC32
9およびTMV(7)RNA、+7)cDNAを組み込
んだ転写ベクターpLFW3のDNA構造を表す図であ
る。 第4図は、プラスミドpLM31.pLM51゜pLW
F 1、pLWF3、およびp−L−1−13のDNA
構造を表す図である。 第5図は、pUcG91、pLFWl、pLFW3のM
 l u Iサイト周辺のDNA配列を表す図である。 第6図は、CATの発現を確認する実験におけるオート
ラジオグラフィーの結果を示す図である。 完 一25= 特fL’JR,VG3−14693 (9)l  − −H d  φ  ! ω  ■  Σ1「÷1 →−〉 藁 ; あ 旧 6諧 jを 第5図 pUcG91のM l u Iサイト周辺のDNA配列
pLFW1のMluIサイト周辺のDNA配列ApaI
 Mlul pLFW3のM 1 u Iサイト周辺のDNA配列A
paI MluI 第6図 1.3AcCm 0 0、    IAcCm lAcCm000 0DO4567
FIG. 1 is a diagram schematically showing the construction of the transcription vector pCL29 of the present invention. In the figure, Pm is λ derived from pPM1 developed by Ahlquist.
Represents the phage promoter. 130/180K, 30 and cp 1 of TMV
30/180 represents a protein gene, 30 represents a protein gene and a coat protein gene. 5 and 3 enclosed in squares before and after represent the 5° terminal untranslated region and the 3'' terminal untranslated region, respectively. Figure 2 shows the universal transcription vector pLDC329.
It is a diagram showing an outline of construction. Figure 3 shows transcription vector pCL29 containing the CAT gene.
(pCL, B29), transcription vector pLDC32
FIG. 9 is a diagram showing the DNA structure of transcription vector pLFW3 incorporating TMV (7) RNA and +7) cDNA. FIG. 4 shows plasmid pLM31. pLM51゜pLW
DNA of F 1, pLWF3, and p-L-1-13
FIG. Figure 5 shows the M of pUcG91, pLFWl, pLFW3.
FIG. 2 is a diagram showing the DNA sequence around the l u I site. FIG. 6 is a diagram showing the results of autoradiography in an experiment to confirm the expression of CAT. Kanichi 25 = special fL'JR, VG3-14693 (9) l - -H d φ! ω ■ Σ1 "÷ 1 → ->Straw; Old 6th scale j Fig. 5 DNA sequence around the Mlu I site of pUcG91 DNA sequence around the Mlu I site of pLFW1 ApaI
DNA sequence A around the M 1 u I site of Mlul pLFW3
paI MluI Figure 6 1.3AcCm 0 0, IAcCm lAcCm000 0DO4567

Claims (7)

【特許請求の範囲】[Claims] (1)トバモウイルスRNAのコートタンパク遺伝子領
域を外来遺伝子で置換することにより製造した植物RN
Aベクター
(1) Plant RN produced by replacing the coat protein gene region of tobamovirus RNA with a foreign gene
A vector
(2)トバモウイルスRNAのコートタンパク遺伝子領
域が外来遺伝子で置換された配列を有するトバモウイル
スRNAを転写産物とする転写ベクター
(2) A transcription vector whose transcription product is tobamovirus RNA, which has a sequence in which the coat protein gene region of tobamovirus RNA is replaced with a foreign gene.
(3)複製開始領域、選択マーカー、プロモーターおよ
びコートタンパク遺伝子領域が外来遺伝子で置換された
配列のトバモウイルスRNAのcDNAからなり、該プ
ロモーターの転写開始ヌクレオチドが該cDNAの最初
のヌクレオチドであるように接続されている特許請求の
範囲第2項記載の転写ベクター
(3) Consists of a tobamovirus RNA cDNA in which the replication initiation region, selection marker, promoter, and coat protein gene region are replaced with foreign genes, and connected so that the transcription initiation nucleotide of the promoter is the first nucleotide of the cDNA. The transcription vector according to claim 2
(4)プロモーターがλファージのプロモーターである
ことを特徴とする特許請求の範囲第2あるいは3項記載
の転写ベクター
(4) The transcription vector according to claim 2 or 3, wherein the promoter is a λ phage promoter.
(5)複製開始領域、選択マーカー、プロモーターおよ
びコートタンパク遺伝子領域が外来遺伝子挿入のための
制限酵素切断部位へ変換された配列のトバモウイルスR
NAのcDNAから成り、該プロモーターの転写開始ヌ
クレオチドが該cDNAの最初のヌクレオチドであるよ
うに接続されているユニバーサル転写ベクター
(5) Tobamovirus R with a sequence in which the replication initiation region, selection marker, promoter, and coat protein gene region have been converted into restriction enzyme cleavage sites for foreign gene insertion
A universal transcription vector consisting of a cDNA of NA, connected such that the transcription initiation nucleotide of the promoter is the first nucleotide of the cDNA.
(6)pLDCS29として特定される特許請求の範囲
第5項記載のユニバーサル転写ベクター
(6) Universal transcription vector according to claim 5 specified as pLDCS29
(7)トバモウイルスRNAのコートタンパク遺伝子領
域を外来遺伝子で置換することにより製造した植物RN
Aベクター、あるいは該植物RNAベクターを用い再構
成したウイルスを接種することを特徴とする植物細胞へ
外来遺伝子を組み込む方法
(7) Plant RN produced by replacing the coat protein gene region of tobamovirus RNA with a foreign gene
A method for integrating a foreign gene into a plant cell, which comprises inoculating a virus reconstituted using the A vector or the plant RNA vector.
JP61158443A 1986-07-04 1986-07-04 Plant virus rna vector Pending JPS6314693A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61158443A JPS6314693A (en) 1986-07-04 1986-07-04 Plant virus rna vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61158443A JPS6314693A (en) 1986-07-04 1986-07-04 Plant virus rna vector

Publications (1)

Publication Number Publication Date
JPS6314693A true JPS6314693A (en) 1988-01-21

Family

ID=15671878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61158443A Pending JPS6314693A (en) 1986-07-04 1986-07-04 Plant virus rna vector

Country Status (1)

Country Link
JP (1) JPS6314693A (en)

Cited By (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866785A (en) * 1988-02-26 1999-02-02 Biosource Technologies, Inc. Recombinant plant viral nucleic acids
US5889191A (en) * 1992-12-30 1999-03-30 Biosource Technologies, Inc. Viral amplification of recombinant messenger RNA in transgenic plants
US5965794A (en) * 1992-12-30 1999-10-12 Biosource Technologies, Inc. Viral amplification of recombinant messenger RNA in transgenic plants
US5977438A (en) * 1988-02-26 1999-11-02 Biosource Technologies, Inc. Production of peptides in plants as viral coat protein fusions
US6054566A (en) * 1988-02-26 2000-04-25 Biosource Technologies, Inc. Recombinant animal viral nucleic acids
US6284492B1 (en) 1988-02-26 2001-09-04 Large Scale Biology Corporation Recombinant animal viral nucleic acids
US6660500B2 (en) 1988-02-26 2003-12-09 Large Scale Biology Corporation Production of peptides in plants as viral coat protein fusions
US7033835B1 (en) 1988-02-26 2006-04-25 Large Scale Biology Corporation Production of peptides in plants as viral coat protein fusions
WO2007020638A2 (en) 2005-08-15 2007-02-22 Evogene Ltd. Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
WO2008010228A2 (en) 2006-07-20 2008-01-24 Yeda Research And Development Co. Ltd. Photosyntheticorganisms and compositions and methods of generating same
WO2008122980A2 (en) 2007-04-09 2008-10-16 Evogene Ltd. Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
WO2009083958A2 (en) 2007-12-27 2009-07-09 Evogene Ltd. Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
WO2010049897A2 (en) 2008-10-30 2010-05-06 Evogene Ltd. Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny
WO2010076756A2 (en) 2008-12-29 2010-07-08 Evogene Ltd. Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
WO2010100595A2 (en) 2009-03-02 2010-09-10 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
US7906705B2 (en) 2006-07-03 2011-03-15 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center Polynucleotides and polypeptides encoded therefrom and methods of using same for increasing biomass in plants and plants generated thereby
WO2011048600A1 (en) 2009-10-21 2011-04-28 Danziger Innovations Ltd. Generating genotypic variations in plant genomes by gamete infection
EP2316950A1 (en) 2000-03-27 2011-05-04 Technion Research and Development Foundation, Ltd. Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same
WO2011067745A2 (en) 2009-12-06 2011-06-09 Rosetta Green Ltd. Compositions and methods for enhancing plants resistance to abiotic stress
EP2336330A2 (en) 2004-06-14 2011-06-22 Evogene Ltd. Polynucleotides and polypeptides involved in plant fiber development and methods of using same
WO2011080674A2 (en) 2009-12-28 2011-07-07 Evogene Ltd. Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
WO2011099006A2 (en) 2010-02-11 2011-08-18 Yeda Research And Development Co. Ltd. Enzymatic systems for carbon fixation and methods of generating same
EP2365087A2 (en) 2003-05-22 2011-09-14 Evogene Ltd. Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
EP2383345A1 (en) 2006-12-20 2011-11-02 Evogene Ltd. Polynucleotides and polypeptides involved in plant fiber development and methods of using same
WO2011135527A2 (en) 2010-04-28 2011-11-03 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
WO2011158242A2 (en) 2010-06-16 2011-12-22 Futuragene Israel Ltd. Pest -resistant plants containing a combination of a spider toxin and a chitinase
WO2012007919A2 (en) 2010-07-15 2012-01-19 Technion Research & Development Foundation Ltd. Nucleic acid construct for increasing abiotic stress tolerance in plants
WO2012007945A2 (en) 2010-07-12 2012-01-19 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center Isolated polynucleotides and methods and plants using same for regulating plant acidity
WO2012032520A1 (en) 2010-09-07 2012-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
EP2441840A1 (en) 2005-07-18 2012-04-18 Protalix Ltd. Mucosal or enteral administration of biologically active macromolecules
WO2012059922A2 (en) 2010-11-03 2012-05-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Transgenic plants with improved saccharification yields and methods of generating same
WO2012098537A1 (en) 2011-01-20 2012-07-26 Protalix Ltd. Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
WO2012117406A2 (en) 2011-03-02 2012-09-07 Futuragene Israel Ltd. Bacterial resistant transgenic plants
WO2012156976A1 (en) 2011-05-16 2012-11-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of producing artemisinin in non-host plants and vectors for use in same
EP2599790A1 (en) 2007-11-26 2013-06-05 Yissum Research Development Company of The Hebrew University of Jerusalem Compositions comprising fibrous polypeptides and polysachharides
WO2013088438A1 (en) 2011-12-11 2013-06-20 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center Methods of modulating stomata conductance and plant expression constructs for executing same
WO2013114371A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Dry powder formulations of dnase i
WO2013121405A1 (en) 2012-02-19 2013-08-22 Protalix Ltd. Oral unit dosage forms and uses of same for the treatment of gaucher disease
WO2014033723A1 (en) 2012-09-03 2014-03-06 A.B. Seeds Ltd. Method of improving abiotic stress tolerance of plants and plants generated thereby
EP2716654A1 (en) 2005-10-24 2014-04-09 Evogene Ltd. Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
WO2014136113A1 (en) 2013-03-06 2014-09-12 Protalix Ltd. Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
WO2014136117A1 (en) 2013-03-06 2014-09-12 Protalix Ltd. USE OF PLANT CELLS EXPRESSING A TNFalpha POLYPEPTIDE INHIBITOR IN THERAPY
EP2816117A2 (en) 2004-09-29 2014-12-24 Collplant Ltd. Collagen producing plants and methods of generating and using same
WO2015118547A1 (en) 2014-02-10 2015-08-13 Protalix Ltd. Method of maintaining disease stability in a subject having gaucher's disease
EP2910638A2 (en) 2007-07-24 2015-08-26 Evogene Ltd. Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
EP2936976A1 (en) 2008-04-21 2015-10-28 Danziger Innovations Ltd. Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
EP3020410A1 (en) 2008-04-18 2016-05-18 Collplant Ltd. Methods of generating and using procollagen
WO2016079739A2 (en) 2014-11-20 2016-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
WO2016084084A1 (en) 2014-11-27 2016-06-02 Danziger Innovations Ltd. Nucleic acid constructs for genome editing
EP3072972A2 (en) 2008-08-18 2016-09-28 Evogene Ltd. Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants
WO2017125931A1 (en) 2016-01-21 2017-07-27 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Parthenocarpic plants and methods of producing same
EP3238534A2 (en) 2009-06-10 2017-11-01 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
WO2018220581A1 (en) 2017-05-31 2018-12-06 Tropic Biosciences UK Limited Compositions and methods for increasing shelf-life of banana
WO2018220579A1 (en) 2017-05-31 2018-12-06 Tropic Biosciences UK Limited Compositions and methods for increasing extractability of solids from coffee beans
WO2018220582A1 (en) 2017-05-31 2018-12-06 Tropic Biosciences UK Limited Methods of selecting cells comprising genome editing events
WO2018224861A1 (en) 2017-06-07 2018-12-13 International Rice Research Institute Increasing hybrid seed production through higher outcrossing rate in cytoplasmic male sterile gramineae plants and related materials and methods
WO2019106638A1 (en) 2017-12-03 2019-06-06 Seedx Technologies Inc. Systems and methods for sorting of seeds
WO2019211854A1 (en) 2018-05-03 2019-11-07 Collplant Holdings Ltd. Dermal fillers and applications thereof
WO2019211750A1 (en) 2018-05-01 2019-11-07 Tropic Biosciences UK Limited Compositions and methods for reducing caffeine content in coffee beans
WO2019234750A1 (en) 2018-06-07 2019-12-12 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Methods of regenerating and transforming cannabis
WO2019234754A1 (en) 2018-06-07 2019-12-12 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Nucleic acid constructs and methods of using same
WO2020183414A2 (en) 2019-03-14 2020-09-17 Tropic Biosciences UK Limited Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
WO2020183419A1 (en) 2019-03-14 2020-09-17 Tropic Biosciences UK Limited Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
WO2020183416A1 (en) 2019-03-14 2020-09-17 Tropic Biosciences UK Limited PRODUCTION OF dsRNA IN PLANT CELLS FOR PEST PROTECTION VIA GENE SILENCING
WO2021001784A1 (en) 2019-07-04 2021-01-07 Ukko Inc. De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
WO2021019536A1 (en) 2019-07-30 2021-02-04 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
WO2021100034A1 (en) 2019-11-19 2021-05-27 Protalix Ltd. Removal of constructs from transformed cells
WO2021202513A1 (en) 2020-03-31 2021-10-07 Elo Life Systems Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits
WO2022038536A1 (en) 2020-08-18 2022-02-24 International Rice Research Institute Methods of increasing outcrossing rates in gramineae
WO2022074646A1 (en) 2020-10-05 2022-04-14 Protalix Ltd. Dicer-like knock-out plant cells
WO2022087527A1 (en) 2020-10-23 2022-04-28 Elo Life Systems, Inc. Methods for producing vanilla plants with improved flavor and agronomic production
WO2022115498A1 (en) 2020-11-26 2022-06-02 Ukko Inc. Modified high molecular weight glutenin subunit and uses thereof
WO2022226316A1 (en) 2021-04-22 2022-10-27 Precision Biosciences, Inc. Compositions and methods for generating male sterile plants
EP4170029A2 (en) 2017-09-19 2023-04-26 Tropic Biosciences UK Limited Modifying the specifity of plant non-coding rna molecules for silencing gene expression

Cited By (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660500B2 (en) 1988-02-26 2003-12-09 Large Scale Biology Corporation Production of peptides in plants as viral coat protein fusions
US7192740B2 (en) 1988-02-26 2007-03-20 Large Scale Biology Corporation Recombinant viral nucleic acids
US5889190A (en) * 1988-02-26 1999-03-30 Biosource Technologies, Inc. Recombinant plant viral nucleic acids
US5866785A (en) * 1988-02-26 1999-02-02 Biosource Technologies, Inc. Recombinant plant viral nucleic acids
US5977438A (en) * 1988-02-26 1999-11-02 Biosource Technologies, Inc. Production of peptides in plants as viral coat protein fusions
US6054566A (en) * 1988-02-26 2000-04-25 Biosource Technologies, Inc. Recombinant animal viral nucleic acids
US6284492B1 (en) 1988-02-26 2001-09-04 Large Scale Biology Corporation Recombinant animal viral nucleic acids
US7033835B1 (en) 1988-02-26 2006-04-25 Large Scale Biology Corporation Production of peptides in plants as viral coat protein fusions
US5965794A (en) * 1992-12-30 1999-10-12 Biosource Technologies, Inc. Viral amplification of recombinant messenger RNA in transgenic plants
US6852846B2 (en) 1992-12-30 2005-02-08 Large Scale Biology Corporation Viral amplification of recombinant messenger RNA in transgenic plants
US6462255B1 (en) 1992-12-30 2002-10-08 Large Scale Biology Corporation Viral amplification of recombinant messenger RNA in transgenic plants
US5889191A (en) * 1992-12-30 1999-03-30 Biosource Technologies, Inc. Viral amplification of recombinant messenger RNA in transgenic plants
EP2316950A1 (en) 2000-03-27 2011-05-04 Technion Research and Development Foundation, Ltd. Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same
EP2365087A2 (en) 2003-05-22 2011-09-14 Evogene Ltd. Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
EP2343373A1 (en) 2004-06-14 2011-07-13 Evogene Ltd. Polynucleotides and polypeptides involved in plant fiber development and methods of using same
EP2336330A2 (en) 2004-06-14 2011-06-22 Evogene Ltd. Polynucleotides and polypeptides involved in plant fiber development and methods of using same
EP3088528A1 (en) 2004-09-29 2016-11-02 Collplant Ltd. Collagen producing plants and methods of generating and using same
EP2816117A2 (en) 2004-09-29 2014-12-24 Collplant Ltd. Collagen producing plants and methods of generating and using same
EP2484768A2 (en) 2005-07-18 2012-08-08 Protalix Ltd. Mucosal or enteral administration of biologically active macromolecules
EP2441840A1 (en) 2005-07-18 2012-04-18 Protalix Ltd. Mucosal or enteral administration of biologically active macromolecules
EP2995194A1 (en) 2005-08-15 2016-03-16 Evogene Ltd. Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
WO2007020638A2 (en) 2005-08-15 2007-02-22 Evogene Ltd. Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
EP2716654A1 (en) 2005-10-24 2014-04-09 Evogene Ltd. Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
US7906705B2 (en) 2006-07-03 2011-03-15 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center Polynucleotides and polypeptides encoded therefrom and methods of using same for increasing biomass in plants and plants generated thereby
WO2008010228A2 (en) 2006-07-20 2008-01-24 Yeda Research And Development Co. Ltd. Photosyntheticorganisms and compositions and methods of generating same
EP2383345A1 (en) 2006-12-20 2011-11-02 Evogene Ltd. Polynucleotides and polypeptides involved in plant fiber development and methods of using same
WO2008122980A2 (en) 2007-04-09 2008-10-16 Evogene Ltd. Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
EP2910638A2 (en) 2007-07-24 2015-08-26 Evogene Ltd. Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
EP2599790A1 (en) 2007-11-26 2013-06-05 Yissum Research Development Company of The Hebrew University of Jerusalem Compositions comprising fibrous polypeptides and polysachharides
WO2009083958A2 (en) 2007-12-27 2009-07-09 Evogene Ltd. Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
EP3020410A1 (en) 2008-04-18 2016-05-18 Collplant Ltd. Methods of generating and using procollagen
EP2936976A1 (en) 2008-04-21 2015-10-28 Danziger Innovations Ltd. Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
EP3616504A2 (en) 2008-08-18 2020-03-04 Evogene Ltd. Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants
EP3072972A2 (en) 2008-08-18 2016-09-28 Evogene Ltd. Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants
WO2010049897A2 (en) 2008-10-30 2010-05-06 Evogene Ltd. Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny
WO2010076756A2 (en) 2008-12-29 2010-07-08 Evogene Ltd. Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
WO2010100595A2 (en) 2009-03-02 2010-09-10 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
EP3000889A2 (en) 2009-03-02 2016-03-30 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
EP3626051A2 (en) 2009-06-10 2020-03-25 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
EP3238534A2 (en) 2009-06-10 2017-11-01 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
WO2011048600A1 (en) 2009-10-21 2011-04-28 Danziger Innovations Ltd. Generating genotypic variations in plant genomes by gamete infection
US9562235B2 (en) 2009-12-06 2017-02-07 A.B. Seeds Ltd. MicroRNA compositions and methods for enhancing plant resistance to abiotic stress
WO2011067745A2 (en) 2009-12-06 2011-06-09 Rosetta Green Ltd. Compositions and methods for enhancing plants resistance to abiotic stress
WO2011080674A2 (en) 2009-12-28 2011-07-07 Evogene Ltd. Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
WO2011099006A2 (en) 2010-02-11 2011-08-18 Yeda Research And Development Co. Ltd. Enzymatic systems for carbon fixation and methods of generating same
WO2011135527A2 (en) 2010-04-28 2011-11-03 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
WO2011158242A2 (en) 2010-06-16 2011-12-22 Futuragene Israel Ltd. Pest -resistant plants containing a combination of a spider toxin and a chitinase
WO2012007945A2 (en) 2010-07-12 2012-01-19 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center Isolated polynucleotides and methods and plants using same for regulating plant acidity
WO2012007919A2 (en) 2010-07-15 2012-01-19 Technion Research & Development Foundation Ltd. Nucleic acid construct for increasing abiotic stress tolerance in plants
WO2012032520A1 (en) 2010-09-07 2012-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
WO2012059922A2 (en) 2010-11-03 2012-05-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Transgenic plants with improved saccharification yields and methods of generating same
WO2012098537A1 (en) 2011-01-20 2012-07-26 Protalix Ltd. Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
WO2012117406A2 (en) 2011-03-02 2012-09-07 Futuragene Israel Ltd. Bacterial resistant transgenic plants
WO2012156976A1 (en) 2011-05-16 2012-11-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of producing artemisinin in non-host plants and vectors for use in same
WO2013088438A1 (en) 2011-12-11 2013-06-20 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center Methods of modulating stomata conductance and plant expression constructs for executing same
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I
WO2013114373A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Inhalable liquid formulations of dnase i
WO2013114371A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Dry powder formulations of dnase i
WO2013114374A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
US9603907B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Dry powder formulations of dNase I
WO2013121405A1 (en) 2012-02-19 2013-08-22 Protalix Ltd. Oral unit dosage forms and uses of same for the treatment of gaucher disease
WO2014033723A1 (en) 2012-09-03 2014-03-06 A.B. Seeds Ltd. Method of improving abiotic stress tolerance of plants and plants generated thereby
WO2014136117A1 (en) 2013-03-06 2014-09-12 Protalix Ltd. USE OF PLANT CELLS EXPRESSING A TNFalpha POLYPEPTIDE INHIBITOR IN THERAPY
WO2014136114A1 (en) 2013-03-06 2014-09-12 Protalix Ltd. TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
WO2014136113A1 (en) 2013-03-06 2014-09-12 Protalix Ltd. Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
WO2015118547A1 (en) 2014-02-10 2015-08-13 Protalix Ltd. Method of maintaining disease stability in a subject having gaucher's disease
WO2016079739A2 (en) 2014-11-20 2016-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
WO2016084084A1 (en) 2014-11-27 2016-06-02 Danziger Innovations Ltd. Nucleic acid constructs for genome editing
WO2017125931A1 (en) 2016-01-21 2017-07-27 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Parthenocarpic plants and methods of producing same
WO2018220582A1 (en) 2017-05-31 2018-12-06 Tropic Biosciences UK Limited Methods of selecting cells comprising genome editing events
WO2018220579A1 (en) 2017-05-31 2018-12-06 Tropic Biosciences UK Limited Compositions and methods for increasing extractability of solids from coffee beans
WO2018220581A1 (en) 2017-05-31 2018-12-06 Tropic Biosciences UK Limited Compositions and methods for increasing shelf-life of banana
WO2018224861A1 (en) 2017-06-07 2018-12-13 International Rice Research Institute Increasing hybrid seed production through higher outcrossing rate in cytoplasmic male sterile gramineae plants and related materials and methods
EP4170029A2 (en) 2017-09-19 2023-04-26 Tropic Biosciences UK Limited Modifying the specifity of plant non-coding rna molecules for silencing gene expression
WO2019106638A1 (en) 2017-12-03 2019-06-06 Seedx Technologies Inc. Systems and methods for sorting of seeds
WO2019211750A1 (en) 2018-05-01 2019-11-07 Tropic Biosciences UK Limited Compositions and methods for reducing caffeine content in coffee beans
WO2019211854A1 (en) 2018-05-03 2019-11-07 Collplant Holdings Ltd. Dermal fillers and applications thereof
US11801329B2 (en) 2018-05-03 2023-10-31 Collplant Ltd. Dermal fillers and applications thereof
WO2019234754A1 (en) 2018-06-07 2019-12-12 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Nucleic acid constructs and methods of using same
WO2019234750A1 (en) 2018-06-07 2019-12-12 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Methods of regenerating and transforming cannabis
WO2020183414A2 (en) 2019-03-14 2020-09-17 Tropic Biosciences UK Limited Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
WO2020183416A1 (en) 2019-03-14 2020-09-17 Tropic Biosciences UK Limited PRODUCTION OF dsRNA IN PLANT CELLS FOR PEST PROTECTION VIA GENE SILENCING
WO2020183419A1 (en) 2019-03-14 2020-09-17 Tropic Biosciences UK Limited Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
WO2021001784A1 (en) 2019-07-04 2021-01-07 Ukko Inc. De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
WO2021019536A1 (en) 2019-07-30 2021-02-04 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
WO2021100034A1 (en) 2019-11-19 2021-05-27 Protalix Ltd. Removal of constructs from transformed cells
WO2021202513A1 (en) 2020-03-31 2021-10-07 Elo Life Systems Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits
WO2022038536A1 (en) 2020-08-18 2022-02-24 International Rice Research Institute Methods of increasing outcrossing rates in gramineae
WO2022074646A1 (en) 2020-10-05 2022-04-14 Protalix Ltd. Dicer-like knock-out plant cells
WO2022087527A1 (en) 2020-10-23 2022-04-28 Elo Life Systems, Inc. Methods for producing vanilla plants with improved flavor and agronomic production
WO2022115498A1 (en) 2020-11-26 2022-06-02 Ukko Inc. Modified high molecular weight glutenin subunit and uses thereof
WO2022226316A1 (en) 2021-04-22 2022-10-27 Precision Biosciences, Inc. Compositions and methods for generating male sterile plants

Similar Documents

Publication Publication Date Title
JPS6314693A (en) Plant virus rna vector
Meshi et al. In vitro transcription of infectious RNAs from full-length cDNAs of tobacco mosaic virus
US5846795A (en) RNA transformation vector
US5162601A (en) Plant potyvirus expression vector with a gene for protease
JP5745857B2 (en) Protein expression system
Turpen et al. Transfection of whole plants from wounds inoculated with Agrobacterium tumefaciens containing cDNA of tobacco mosaic virus
EP1013771B1 (en) Non-nuclear chromosomal transformation
US5633447A (en) Plant tissue comprising a subgenomic promoter
JPH0231683A (en) Transfer activating element of t-dna 780 gene
JPS61502166A (en) Improved methods and vectors for transformation of plant cells
US5443969A (en) RNA packaging system
EP2118291B1 (en) Artificial DNA sequence with optimized leader function in 5&#39; (5&#39;-UTR) for the improved expression of heterologous proteins in plants
Angenent et al. Biological activity of transcripts synthesized in vitro from full-length and mutated DNA copies of tobacco rattle virus RNA 2
TWI480375B (en) Glycosyltransferase promoter from a medicinal herb on gene regulation and application
Nagata et al. Simplified methods for the construction of RNA and DNA virus infectious clones
Ahlquist In vitro transcription of infectious viral RNA from cloned cDNA
EP0494215A1 (en) Light-activatable plant promoter
US6664384B1 (en) Duplicated cassava vein mosaic virus enhancers and uses thereof
KR100609565B1 (en) Plant Expression Vector Containing Full Genome of YMV-KYam Mosaic Virus-K
JPH0249591A (en) Plant virus rna vector
RU2237717C2 (en) Recombinant plasmid pgbp450f for preparing transgenic plants and method for preparing transgenic tobacco plants with enhanced productivity and resistance to fungal phytopathogens
US5428144A (en) Maize dwarf mosaic virus cDNA
CA1332718C (en) Expression cassette for plants
WO1998044136A9 (en) Genetic method for producing virus resistant organisms
WO1998044136A1 (en) Genetic method for producing virus resistant organisms